Medical Research
(H20)
990 on File
THE AMERICAN SOCIETY OF GENE & CELL THERAPY
Financial strength (30%)
91/100
Reliability (20%)
55/100
Effectiveness (25%)
85/100
Impact (25%)
No data yet
Register and add impact metrics to be rated above three stars
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$16.9M
Total Revenue
$14.6M
Total Expenses
$20.3M
Net Assets
48
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
80.1%
Fundraising Efficiency
N/A
Operating Reserve
16.72x
Liability-to-Asset
24.9%
Revenue Diversification
92.4%
Executive Compensation
$618K
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
80.1% | 82.0% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
14.2% | 12.7% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
5.6% | 0.7% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
16.7 mo | 14.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
24.9% | 21.3% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
92.4% | 90.8% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
3.3% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
6.0% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
13.8% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $16.9M | $14.6M | $20.3M | 80.1% | 48 |
| 2023 | $16.4M | $13.8M | $17.2M | 81.7% | 45 |
| 2022 | $12.5M | $11.0M | $14.2M | 81.9% | 40 |
| 2021 | $9.2M | $6.2M | N/A | — | 30 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.